Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

pegs1, due to the NIH trial failure, I have assumed that NRXP has abandoned EUA for aviptadil. They have PR'd that they are focused now on their other drug. However, there are other ongoing studies (ex: Swiss inhaler trial) that could prove promising. However, IMO that study is too underpowered to pursue anything with the FDA. But the inhaler version of aviptadil could have some viable applications for RLFTF downstream.

We know that RLFTF is waiting to get their hands on the NIH trial 'data'. So we'll have to wait and see what RLFTF thinks about that data.

I feel that obtaining FDA approval for ACER-001 is the next significant milestone for both RLFTF and ACER. That should give both PPS's a small lift. They need to get past the FDA "inspection" milestone first. What a blunder that was!